New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 24, 2014
07:48 EDTZGNXMedia coverage of Zogenix drug becoming more balanced, says Oppenheimer
Oppenheimer believes that the media's coverage of Zogenix's Zohydro is becoming less negative. The firm thinks that this change could ease headline pressure on the stock. Oppenheimer keeps a $5 price target and Outperform rating on the shares.
News For ZGNX From The Last 14 Days
Check below for free stories on ZGNX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
17:15 EDTZGNXArmistice Capital reports 5.9% passive stake in Zogenix
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use